Nouvelle déclaration d'incident
No de la demande: 2009-5455
Numéro de référence du titulaire d'homologation: Prosar 1-16819623
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: CANADA
État: ONTARIO
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Permethrin, Methoprene Based Flea and Tick Product for Dogs
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Non
Professionnel de la santé
Cat / Chat
Unknown breed
1
Inconnu
Inconnu
Inconnu
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Oui
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-16819623: A reporter (veterinarian) called on 11/05/2008 to report the exposure of two cats to a canine flea and tick product containing the active ingredients Permethrin and Methoprene. According to the reporter, the product was applied to both cats on 11/04/2008. At an unknown time following product application, both cats presented to the veterinarian with signs of tremors, seizures, and hyperthermia. It is unknown what therapy was instituted prior to the report, but at one point the cats both became hypothermic and were being warmed at the time of the report. The reporter requested further treatment information. The reporter was advised that cats are very sensitive to high concentrations of pyrethroids as found in the canine product. Both hyperthermia and hypothermia are possible with exposure to high concentrations of pyrethroids. The reporter was advised that there is no antidote for pyrethroid toxicity. A recommendation was made to bathe both cats in non-insecticidal shampoo or hand dish soap. Treatment consists of symptomatic and supportive care. The management of tremors and seizures was discussed. A recommendation was made to monitor the cats for 48-72 hours. On follow up on 11/06/2008, the reporter stated that the cats¿ tremors and seizures had resolved following treatment with Methocarbamol and Phenobarbital. Both cats had received fluid therapy. The cats were able to swallow on their own at the time of the follow up. Cat #1 (1st Subform III) had become hyperthermic again (105-106 degrees F). The reporter inquired about the continuation of Methocarbamol and how to best address the hyperthermia. The reporter was advised to continue the Methocarbamol as signs can re-develop for up to 72 hours if treatment is discontinued too soon. The reporter was provided with several options to help cool Cat#1. A recommendation was made to stop the cooling procedures once the cat¿s temperature reached 103 degrees F to prevent over-cooling and the development of hypothermia. On follow up on 11/10/2008, a veterinary hospital employee stated that Cat#1 had died after the hyperthermia persisted and seizures recurred. Cat#2 (2nd Subform III) was doing okay as far as the employee knew at the time of follow up. Both cats had been discharged on an unknown date. NOTE: This product is a canine product not labeled for use in cats.
Mort
Professionnel de la santé
Cat / Chat
Unknown breed
1
Inconnu
Inconnu
Inconnu
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Oui
Oui
Inconnu
Fully Recovered / Complètement rétabli
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-16819623: A reporter (veterinarian) called on 11/05/2008 to report the exposure of two cats to a canine flea and tick product containing the active ingredients Permethrin and Methoprene. According to the reporter, the product was applied to both cats on 11/04/2008. At an unknown time following product application, both cats presented to the veterinarian with signs of tremors, seizures, and hyperthermia. It is unknown what therapy was instituted prior to the report, but at one point the cats both became hypothermic and were being warmed at the time of the report. The reporter requested further treatment information. The reporter was advised that cats are very sensitive to high concentrations of pyrethroids as found in the canine product. Both hyperthermia and hypothermia are possible with exposure to high concentrations of pyrethroids. The reporter was advised that there is no antidote for pyrethroid toxicity. A recommendation was made to bathe both cats in non-insecticidal shampoo or hand dish soap. Treatment consists of symptomatic and supportive care. The management of tremors and seizures was discussed. A recommendation was made to monitor the cats for 48-72 hours. On follow up on 11/06/2008, the reporter stated that the cats¿ tremors and seizures had resolved following treatment with Methocarbamol and Phenobarbital. Both cats had received fluid therapy. The cats were able to swallow on their own at the time of the follow up. Cat #1 (1st Subform III) had become hyperthermic again (105-106 degrees F). The reporter inquired about the continuation of Methocarbamol and how to best address the hyperthermia. The reporter was advised to continue the Methocarbamol as signs can re-develop for up to 72 hours if treatment is discontinued too soon. The reporter was provided with several options to help cool Cat#1. A recommendation was made to stop the cooling procedures once the cat¿s temperature reached 103 degrees F to prevent over-cooling and the development of hypothermia. On follow up on 11/10/2008, a veterinary hospital employee stated that Cat#1 had died after the hyperthermia persisted and seizures recurred. Cat#2 (2nd Subform III) was doing okay as far as the employee knew at the time of follow up. Both cats had been discharged on an unknown date. NOTE: This product is a canine product not labeled for use in cats.
Modérée